Here’s what you should know.
1. Cogentix announced in January it agreed to be acquired by Laborie for approximately $239 million.
2. Levi & Korsinsky and Rigrodsky & Long are investigating the sale.
3. When Cogentix Medical President and CEO Darin Hammers referred to the transaction initially, he said, “[It is a] compelling financial opportunity that delivers significant value to our investors who have supported our evolution to becoming a valued player in the urology market.”
4. Neither Cogentix nor Laborie issued a statement in response to the investigation.
More articles on gastroenterology:
Top 10 patient safety concerns for 2018 — diagnostic errors are No. 1
5 things to know about orthopedic surgeon Dr. Shawn Granger
Vanderbilt offers $4.8M for property to build ASC, pediatric clinic — 6 notes
